Transverse Abdominal Block for Analgesia in Casarean Section

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

June 30, 2014

Conditions
Analgesia Disorder
Interventions
DRUG

Bupivacine group

Bupivacaine group(n=30) will receive post-delivery bilateral TAP block with 10 ml of bupivacaine 0.5 % mixed with 10 ml saline and 10 μg dexmetonedine in 20 ml syringe

DRUG

Dexmedetomidine

Dexamedtomedine group will receive post-delivery bilateral TAP block with 10 ml of bupivacaine 0.5 % mixed with 10 ml saline and 10 μg dexmetonedine in 20 ml syringe

Trial Locations (1)

355217

Tanta University Hospitals, Tanta

All Listed Sponsors
lead

Tanta University

OTHER

NCT02122510 - Transverse Abdominal Block for Analgesia in Casarean Section | Biotech Hunter | Biotech Hunter